Trigeminal Neuralgia | Carbamazepine Response Simulator

A hyperexcitable trigeminal nerve fires severe pain from the lightest facial touch.

Compressed or demyelinated fibers fire spontaneous, exaggerated signals.

Innocuous stimuli near the mouth/nose provoke a full pain paroxysm.

A brief pain-free window follows each attack before re-triggering.

Clinicians gently probe the face to map exact trigger-zone locations.

Hotspots cluster along V2 territory around nose and upper lip.

Zone location predicts which nerve division is involved.

Mapping sets a pre-treatment reference for tracking response.

Carbamazepine binds voltage-gated Na⁺ channels, damping runaway firing.

Drug preferentially blocks channels firing rapidly and repeatedly.

Fewer open channels means fewer ectopic action potentials.

Low starting dose limits sedation while relief begins.

Dose climbs gradually over days to weeks toward effective blockade.

Slow increases balance pain control against side effects.

Carbamazepine speeds its own metabolism over the first weeks.

Attack frequency and trigger sensitivity fall as dose rises.

Most patients reach major attack reduction with tolerable side effects.

Sustained blockade lets nerve firing thresholds recover.

Previously provocative touch no longer reliably triggers pain.

Some patients need dose adjustment or second-line options later.